论文部分内容阅读
目的探讨支气管动脉灌注治疗非小细胞肺癌(NSCLC)的疗效。方法按数字随机法将60例NSCLC患者分为观察组和对照组,每组30例。对照组患者给予全身静脉化疗,观察组患者给予支气管动脉化疗。比较两组患者的近期疗效、不良反应及并发症发生情况。结果观察组患者治疗效果显著优于对照组患者,差异有统计学意义(P<0.05);观察组患者的不良反应和并发症显著少于对照组,差异有统计学意义(P<0.05)。结论支气管动脉灌注化疗治疗非小细胞肺癌,疗效显著,不良反应少,操作简便,对患者损伤较小,易被患者接受,值得临床推广应用。
Objective To investigate the therapeutic effect of bronchial artery infusion on non-small cell lung cancer (NSCLC). Methods Sixty patients with NSCLC were divided into observation group and control group according to the digital randomization method, with 30 cases in each group. Patients in the control group received systemic intravenous chemotherapy and patients in the observation group received bronchial artery chemotherapy. The short-term efficacy, side effects and complications of the two groups were compared. Results The therapeutic effect of the observation group was significantly better than that of the control group (P <0.05). The adverse reactions and complications of the observation group were significantly less than those of the control group (P <0.05). Conclusion Bronchial artery infusion chemotherapy for non-small cell lung cancer has significant curative effect, less adverse reactions, simple operation, less damage to patients and easy acceptance by patients, which is worthy of clinical application.